Please assess the completion status of the following clinical trial:

Trial Title: A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects between 18 and 45 years of age, inclusive~* Healthy males and females with no clinically significant abnormalities identified by a detailed medical history~* Body mass index ≥ 19.0 kg/m2 and ≤ 31.0 kg/m2~Exclusion Criteria:~* Systolic blood pressure \> 130 mmHg or \< 90 mmHg measured after 10 minutes supine at the Screening Visit and Study Day 1~* Diastolic blood pressure \> 90 mmHg or \< 60 mmHg measured after 10 minutes supine at the Screening Visit and Study Day 1~* Heart rate \> 90 bpm or \< 50 bpm measured after 10 minutes supine at the Screening Visit and Study Day~* Known allergy or hypersensitivity to PSE

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- TR-701 FA with PSE (Type: EXPERIMENTAL): TR-701 FA 200 mg oral with PSE
- TR-701 FA Placebo with PSE (Type: PLACEBO_COMPARATOR): TR-701 FA Placebo 200 mg oral with PSE

Based on this trial design, predict the completion outcome and termination type (if applicable).